名稱 | β-thalassemia mutation Reference Standard Ⅸ |
型號 | CBPD0009 |
報價 | |
特點 | β-thalassemia mutation Reference Standard Ⅸ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 【產(chǎn)品推介】VEGFR-2(KDR)小分子抑制劑細(xì)胞篩選模型
- 羅氏乳腺癌新藥獲英國NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- CSF1R細(xì)胞篩選模型
- 熒光素酶檢測試劑盒介紹
- 人結(jié)腸癌細(xì)胞株的生長曲線分析
- PD-1阻斷療法激活的T細(xì)胞還需依賴CD28共刺激
- 【靶點模型+診斷質(zhì)控】BCR-ABL1的藥物開發(fā)和診斷
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
- 新型冠狀病毒:用于診斷的假病毒標(biāo)準(zhǔn)品和用于藥物研發(fā)的假病毒模型
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0009β-thalassemia mutation Reference Standard Ⅸ
- 詳細(xì)內(nèi)容
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Mutation 1 | Variation site: IVS-I-1(G>A) |
DNA Change: c.92+1G>A | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248159C>T | |
Transcript: NM_000518.5 | |
Mutation 2 | Variation site: IVS-I-6(T>C) |
DNA Change: c.92+6T>C | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248154A>G | |
Transcript: NM_000518.5 | |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. IVS-I-1(G>A) Heterozygous Figure 2. IVS-I-6(T>C) Heterozygous |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |